Page last updated: 2024-08-26

syringaresinol and Atrophy

syringaresinol has been researched along with Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, S; Izuo, N; Kim, J; Ozawa, Y; Seo, DB; Shibuya, S; Shimizu, T; Toda, T; Watanabe, K; Yokote, K	1

Other Studies

1 other study(ies) available for syringaresinol and Atrophy

Article	Year
Syringaresinol Reverses Age-Related Skin Atrophy by Suppressing FoxO3a-Mediated Matrix Metalloproteinase-2 Activation in Copper/Zinc Superoxide Dismutase-Deficient Mice. The Journal of investigative dermatology, 2019, Volume: 139, Issue:3 Topics: Animals; Atrophy; Biopsy, Needle; Blotting, Western; Copper; Forkhead Box Protein O3; Furans; Immunohistochemistry; Lignans; Matrix Metalloproteinase 2; Mice; Mice, Hairless; Polymerase Chain Reaction; Skin Aging; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome	2019

Article

Year

Syringaresinol Reverses Age-Related Skin Atrophy by Suppressing FoxO3a-Mediated Matrix Metalloproteinase-2 Activation in Copper/Zinc Superoxide Dismutase-Deficient Mice.

The Journal of investigative dermatology, 2019, Volume: 139, Issue:3

Topics: Animals; Atrophy; Biopsy, Needle; Blotting, Western; Copper; Forkhead Box Protein O3; Furans; Immunohistochemistry; Lignans; Matrix Metalloproteinase 2; Mice; Mice, Hairless; Polymerase Chain Reaction; Skin Aging; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome

2019